Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy

Neuroradiology

Volumn 48, Issue 6, 2006, Pages 428-433

  Waldman, A D ^a,b   Cordery, R J ^a,b   MacManus, D G ^a   Godbolt, A ^a,b   Collinge, J ^a   Rossor, M N ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

CJD; MRI; Prion; Spectroscopy

Indexed keywords

INOSITOL; N ACETYLASPARTIC ACID; PRION PROTEIN;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN REGION; CALCULATION; CASE REPORT; CAUDATE NUCLEUS; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; FATAL FAMILIAL INSOMNIA; FEMALE; FRONTAL LOBE; GENE LOCATION; GENE MUTATION; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; GLIA CELL; HETEROZYGOTE; HUMAN; IN VIVO STUDY; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRION DISEASE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SIGNAL DETECTION; THALAMUS; TISSUE DISTRIBUTION; WHITE MATTER;

ADULT; ASPARTIC ACID; BRAIN; CASE-CONTROL STUDIES; CREATINE; FEMALE; HETEROZYGOTE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PRION DISEASES; PRIONS;

EID: 33745245013     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-006-0068-1     Document Type: Article

References (25)

1. Collinge J, Brown J, Hardy J, Mullan M, Rossor MN, Baker H, et al (1992) Inherited prion disease with 144 base pair gene insertion: II: clinical and pathological features. Brain 115:687-710
2. Collinge J, Palmer MS, Dryden AJ (1991) Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337:1441-1442
3. Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352:340-342
4. Collinge J (2001) Prion diseases of humans and animals: Their causes and molecular basis. Annu Rev Neurosci 24:519-550
5. Zeidler M, Sellar RJ, Collie DA, et al (2000) The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355:1412-1418
6. Collie DA, Sellar RJ, Zeidler M, Colchester ACF, Knight R, Will RG (2001) MRI of Creutzfeldt-Jakob disease: Imaging features and recommended MRI protocol. Clin Radiol 56:726-739
7. Imaiso Y, Mitsuo K (1998) Gerstmann-Straussler-Scheinker syndrome with a Pro102Leu mutation in the prion protein gene and atypical MRI findings, hyperthermia, tachycardia, and hyperhidrosis. Rinsho Shinkeigaku 38:920-925
8. Nitrini R, Mendonca RA, Huang N, LeBlanc A, Livramento JA, Marie SK (2001) Diffusion-weighted MRI in two cases of familial Creutzfeldt-Jakob disease. J Neurol Sci 184:163-167
9. Fox NC, Freeborough PA, Mekkaoui KF, Stevens JM, Rossor MN (1997) Cerebral and cerebellar atrophy on serial magnetic resonance imaging in an initially symptom free subject at risk of familial prion disease. BMJ 4(315):856-857
10. Bruhn H, Weber T, Thorwirth V, Frahm J (1991) In-vivo monitoring of neuronal loss in Creutzfeldt-Jakob disease by proton magnetic resonance spectroscopy. Lancet 337:1610-1611
11. Graham GD, Petroff OAC, Blamire AM, Rajkowska G, Goldman-Rakic P, Prichard JW (1993) Proton magnetic resonance spectroscopy in Creutzfeldt-Jakob disease. Neurology 43:2065-2068
12. Pandya HG, Coley SC, Wilkinson ID, Griffiths PD (2003) Magnetic resonance spectroscopy abnormalities in sporadic and variant Creutzfeldt-Jakob disease. Clin Radiol 58:148-153
13. Galanaud D, Dormont D, Grabli D, Charles P, Hauw JJ, Lubetzki C, Brandel JP, Marsault C, Cozzone PJ (2002) MR spectroscopic pulvinar sign in a case of variant Creutzfeldt-Jakob disease. J Neuroradiol 29:285-287
14. Cordery R, MacManus D, Rossor MN, Collinge J, Waldman AD (2003) Short TE proton spectroscopy in variant and familial Creutzfeldt-Jakob disease. Proc ISMRM,11th Scientific Meeting, p 102
15. Shyu W-C, Lee C-C, Hsu Y-D, et al (1996) Panencephalitic Creutzfeldt-Jakob disease. Unusual presentation of magnetic resonance spectroscopy. J Neurol Sci 138:157-160
16. Konaka K, Kaido M, Okuda Y, et al (2000) Proton magnetic resonance spectroscopy of a patient with Gerstmann-Straussler-Scheinker disease. Neuroradiology 42:662-665
17. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
18. Behar KL, Boucher R, Fritch W, Manuelidis L (1998) Changes in N-acetylaspartate and myo-inositol detected in the cerebral cortex of hamsters with Creutzfeldt-Jakob disease. Magn Reson Imaging 16:963-968
19. Cheng LL, Newell K, Mallory AE, Hyman BT (2002) Gonzalez RG quantification of neurons in Alzheimer and control brains with ex vivo high resolution magic angle spinning proton magnetic resonance spectroscopy and stereology. Magn Reson Imaging 20:527-533
20. Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289-298
21. Strange K, Emma F, Paredes A, Morrison R (1994) Osmoregulatory changes in myo-inositol content and Na+/myo-inositol cotransport in rat cortical astrocytes. Glia 12:35-43
22. Valenzuela MJ, Sachdev P (2001) Magnetic resonance spectroscopy in. Neurology 56:592-598
23. Ironside JW, Bell JE (1997) Florid plaques and new variant Creutzfeldt-Jakob disease. Lancet 350:1475
24. Huang W, Alexander GE, Daly EM, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB (1996) High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome. Am J Psychiatry 156:1879-1886
25. Kantarci K, Jack CR, Xu YC, Campeau NG, O'Brien PC, Smith, GE, Ivnik RJ, Boeve, BF, Kokmen E, Tangalos EG, Petersen RC (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease. Neurology 55:210-217